Pharmalittle: Sanofi experiencing drug shortages, Jazz buying Actio
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…
Pharmalittle: Novo discloses setback, Replimune drug endorsed
And so, another working week will soon come to a close. Not a moment too soon, yes? This…
Pharmalittle: FDA panel nixed Duchenne drug, Hims & Hers sued| STAT
Top of the morning to you, and a fine one it is. Skies are gray but rain is…
Pharmalittle: FDA panel backs pharmacies to make peptides
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
Pharmalittle: Drug shortages rise, GSK cough medicine trials fail
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
Pharmalittle: RFK Jr. pushes against SSRIs, wearable drug okayed
Good morning, everyone, and welcome to another working week. And of course, it is nice to see you…
Pharmalittle: We’re reading about weight loss drug spending, launch prices for medicines, and much more
Top of the morning to you, and a fine one it is. Clear, blue skies and mild breezes…
FDA to review data in real time, SCOTUS hears ‘skinny label’ case
Top of the morning to you. The middle of the week is upon us and, since you made…
We’re reading about China’s GLP-1 drugs, a puzzling FDA rejection
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and rewarding…
We’re reading about Canada speeding drug reviews, Novo ads
Rise and shine, everyone, another busy day is headed your way. And it is getting off to a…
We’re reading about Trump and patent policies, a new malaria drug
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are…
We’re reading about GLP-1 drugs for addiction, FDA funding
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…